Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients

被引:29
|
作者
Bartosik-Psujek, H [1 ]
Stelmasiak, Z [1 ]
机构
[1] Med Univ Lublin, Dept Neurol, PL-20090 Lublin, Poland
关键词
multiple sclerosis; IL-4; IL-12; CCL2; CCL5;
D O I
10.1007/s00702-004-0225-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS). Both cytokines and chemokines have been implicated in the pathogenesis of MS. The aim of the study was to assess whether cytokine levels are correlated with chemokine levels during a different stage of relapsing-remitting MS (RR-MS). The study included 53 patients with RR-MS (20 subjects in stable stage and 18 patients with relapse). By ELISA method, the levels of the interleukin-4 (IL-4), interleukin-12 (IL-12), CCL2 and CCL-5 chemokines were measured both in serum and cerebrospinal fluid (CSF) of all patients. The serum IL-4 and IL-12 levels and CSF CCL5 level of patients with stable RR-MS were significantly different from the control level and the IL-12 levels were correlated with CCL5 levels in serum. During the relapse, a significant change in chemokine levels both in serum and CSF and IL-12 in CSF were noted, however no correlations were found between cytokines and chemokines.
引用
收藏
页码:797 / 803
页数:7
相关论文
共 50 条
  • [1] Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients
    H. Bartosik-Psujek
    Z. Stelmasiak
    Journal of Neural Transmission, 2005, 112 : 797 - 803
  • [2] The CCL2 and CCL5 chemokine levels in serum of multiple sclerosis patients during relapse
    Bartosik-Psujek, H
    Stelmasiak, Z
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S169 - S169
  • [3] Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse
    Rentzos, Michael
    Nikolaou, Chryssoula
    Rombos, Antonis
    Evangelopoulos, M. Eleftheria
    Kararizou, Evangelia
    Koutsis, George
    Zoga, Margarita
    Dimitrakopoulos, Antonis
    Tsoutsou, Anthousa
    Sfangos, Costas
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2008, 110 (10) : 992 - 996
  • [4] Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse
    Bartosik-Psujek, H
    Stelmasiak, Z
    EUROPEAN NEUROLOGY, 2004, 52 (04) : 237 - 241
  • [5] CCL2, IL-1a and leptin levels in cerebrospinal fluid and serum in idiopathic intracranial hypertension
    Dhungana, Samish
    Woodroofe, Nicola
    Sharrack, Basil
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 149 - 149
  • [6] The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease
    Bartosik-Psujek, H
    Stelmasiak, Z
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (01) : 49 - 54
  • [7] The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease
    Bartosik-Psujek, H.
    Stelmasiak, Z.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 263 - 263
  • [8] The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease
    Bartosik-Psujek, H
    Stelmasiak, Z
    JOURNAL OF NEUROLOGY, 2004, 251 : 121 - 122
  • [9] Psoriasis patients generate increased serum levels of autoantibodies to TNF-α and Interferone-α but not to CCL2, CCL3, CCL5 and IL-17
    Bergman, R.
    Ramon, M.
    Wildbaum, G.
    Mayer, E.
    Avitan-Hersh, E.
    Karin, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S13 - S13
  • [10] Serial measurements of levels of the chemokines CCL2, CCL3 and CCL5 in serum of patients with acute ischaemic stroke
    Zaremba, Jaroslaw
    Ilkowski, Jan
    Losy, Jacek
    FOLIA NEUROPATHOLOGICA, 2006, 44 (04) : 282 - 289